Huma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform
New York and London (ots/PRNewswire) - - Class II clearance expands the patient population that can be managed - Companies working with Huma's platform can now launch algorithm innovations more quickly in a compliant and de-risked manner, democratising digital health innovation across the industry - Clearance was ...